Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based Therapies in Left-sided RAS Wild-Type Metastatic Colorectal Cancer
Conditions
- Metastatic Colorectal Cancer
Interventions
- DRUG: Anti-EGFR-Based Therapy
- DRUG: Anti-VEGF-Based Therapy
Sponsor
Pfizer